Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In James Hardie (JHX) To Contact Him Directly To Discuss Their Options If you purchased or acquired James Hardie common stock during the period from May 20, 2025 through August 18, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Melissa Fortunato directly at (212) 355-4648. Click here to participate in the action. NEW YORK, Dec. 16, 2025 (GLOBE NEWSWIR ...

Core Viewpoint - Rosen Law Firm is reminding investors who purchased common stock of James Hardie Industries plc during the specified Class Period of the upcoming lead plaintiff deadline on December 23, 2025 [1]. Group 1: Class Action Details - Investors who bought James Hardie common stock between May 20, 2025, and August 18, 2025, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by contacting Rosen Law Firm [3][6]. - The lead plaintiff must file a motion with the Court by December 23, 2025, to represent other class members in the litigation [3]. Group 2: Case Background - The lawsuit alleges that James Hardie Industries misled investors regarding the performance of its North America Fiber Cement segment during the Class Period, despite knowing about inventory destocking by distributors [5]. - The company falsely claimed that demand was strong and stock levels were normal, leading to investor damages when the true situation was revealed [5]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [4]. - The firm has achieved significant settlements, including the largest securities class action settlement against a Chinese company, and has consistently ranked highly in securities class action settlements [4].

Core Viewpoint - The article discusses a securities class action lawsuit against James Hardie Industries plc, alleging that the company misled investors about the sustainability of growth in its North America Fiber Cement segment, leading to a significant stock price drop of 34% when the truth was revealed [1]. Summary by Relevant Sections Allegations - James Hardie and its executives are accused of falsely claiming that customer inventory levels were "normal" while they were actually experiencing aggressive inventory destocking starting in April and early May 2025 [1]. - The lawsuit claims that sales were inflated due to "inventory loading" by channel partners, which misrepresented the stability of customer demand and inventory levels [1]. Financial Impact - Following the disclosure of a 12% decline in North America Fiber Cement sales, James Hardie's stock dropped over 34%, approximately $9.79 per share [1]. - The lawsuit covers investors who purchased James Hardie securities between May 20, 2025, and August 18, 2025 [1]. Legal Issues - The key legal issues include whether James Hardie misrepresented the stability of customer demand and whether the failure to disclose alleged sales practices violated federal securities laws [1]. - The investigation is also looking into the sudden replacement of the CFO announced on November 17, 2025, as a potential indicator of the alleged issues [1]. Next Steps - Investors who suffered significant losses are encouraged to contact Hagens Berman to discuss their rights, with a lead plaintiff deadline set for December 23, 2025 [1].

Core Insights - Class actions have been initiated for stockholders of James Hardie Industries plc and Baxter International, Inc. with specific deadlines for lead plaintiff petitions [1] James Hardie Industries plc (NYSE:JHX) - The class period for the James Hardie lawsuit is from May 20, 2025, to August 18, 2025 [6] - Allegations include that James Hardie's North America Fiber Cement segment faced weakening demand due to distributor inventory destocking, which the company was aware of by April and early May 2025 [6] - The company falsely represented that demand remained strong and inventory levels were "normal" [6] - On August 19, 2025, a 12% sales decline in the segment was revealed, attributed to "normalization of channel inventories," leading to a share price drop of over 34% [6] Baxter International, Inc. (NYSE:BAX) - The class period for the Baxter lawsuit is from February 23, 2022, to July 30, 2025 [6] - Allegations state that the Novum LVP suffered systemic defects causing malfunctions, which exposed patients to serious risks [6] - Baxter was reportedly notified of multiple device malfunctions, injuries, and deaths related to these defects [6] - The company's attempts to address these issues through customer alerts were deemed inadequate, as design flaws persisted [6] - There was a heightened risk that existing Novum LVPs would be taken out of service, and new sales would be paused, contradicting Baxter's statements about the product's safety and efficacy [6]

Core Viewpoint - The James Hardie Industries plc is facing a class action lawsuit due to alleged misrepresentations regarding its North America Fiber Cement sales performance during a period of inventory destocking, leading to significant stock price decline [1][3][4]. Company Overview - James Hardie Industries plc designs and manufactures a variety of fiber cement building products, with manufacturing facilities located in both the United States and Australia [2]. Class Action Details - The class action lawsuit is titled "Laborers' District Council and Contractors' Pension Fund of Ohio v. James Hardie Industries plc" and is filed in the Northern District of Illinois [1]. - The lawsuit claims that during the class period from May 20, 2025, to August 18, 2025, the company and its executives made false statements about the strength of their sales, despite evidence of inventory destocking [3]. - On August 19, 2025, James Hardie disclosed a 12% decline in North America Fiber Cement sales, which resulted in a stock price drop of over 34% [4]. Legal Process - Investors who purchased James Hardie common stock during the class period can seek appointment as lead plaintiff in the lawsuit, which allows them to represent the interests of all class members [5]. - The lead plaintiff can choose a law firm to litigate the case, and participation as lead plaintiff does not affect the ability to share in any potential recovery [5]. Law Firm Background - Robbins Geller Rudman & Dowd LLP is a leading law firm specializing in securities fraud and shareholder litigation, having secured over $2.5 billion for investors in 2024 alone [6]. - The firm has a strong track record, being ranked 1 in monetary relief for investors in securities class action cases for four out of the last five years [6].

Core Viewpoint - A securities class action lawsuit has been filed against James Hardie Industries plc for failing to disclose material information during the Class Period, leading to significant financial losses for investors [3][4]. Group 1: Lawsuit Details - Investors have until December 23, 2025, to file lead plaintiff applications in the lawsuit against James Hardie, which is pending in the United States District Court for the Northern District of Illinois [1][2]. - The lawsuit alleges that James Hardie and certain executives violated federal securities laws by not disclosing a 12% decline in sales in the North America Fiber Cement segment, which was attributed to customer destocking [3]. - Following the disclosure of the sales decline, James Hardie's share price dropped over 34%, from $28.43 on August 18, 2025, to $18.64 on August 20, 2025, resulting in a loss of $9.79 per share [4]. Group 2: Company Background - Kahn Swick & Foti, LLC (KSF) is a prominent boutique securities litigation law firm, recognized among the top 10 firms nationally based on total settlement value [5]. - KSF represents a diverse range of clients, including institutional and retail investors, in seeking recoveries for investment losses due to corporate fraud or malfeasance [5].

Core Viewpoint - A class action lawsuit has been filed against James Hardie Industries plc for allegedly misleading investors about the strength of its North America Fiber Cement segment during a period of inventory destocking [1][3]. Group 1: Lawsuit Details - The lawsuit is on behalf of investors who acquired James Hardie securities between May 20, 2025, and August 18, 2025, and seeks to recover losses under federal securities laws [1][2]. - Investors have until December 23, 2025, to seek appointment as lead plaintiff if they suffered losses during the Class Period [2]. Group 2: Allegations Against James Hardie - The lawsuit claims that James Hardie made false assurances about the strength of its Fiber Cement segment, despite evidence of inventory destocking starting in April and May 2025 [3]. - It is alleged that the company misrepresented sales as being driven by sustainable customer demand rather than fraudulent channel stuffing practices [3]. Group 3: Financial Impact - On August 19, 2025, James Hardie reported a 12% decline in its North America Fiber Cement segment, attributing it to "normalization of channel inventories" and warned of continued weakness [4]. - Following this disclosure, the company's stock price fell by more than 34%, resulting in significant losses for investors [4].

Core Points - ClaimsFiler has announced that investors in James Hardie Industries plc have until December 23, 2025, to file lead plaintiff applications in a securities class action lawsuit related to the company's share performance during the Class Period from May 20, 2025, to August 18, 2025 [1] - The lawsuit alleges that James Hardie and certain executives failed to disclose material information regarding the company's North America Fiber Cement segment, which saw a 12% decline in sales due to customer destocking [3][4] Company Information - The lawsuit is currently pending in the United States District Court for the Northern District of Illinois, under the case name Laborers' District Council and Contractors' Pension Fund of Ohio v. James Hardie Industries plc, et al., No. 25-cv-13018 [4] - Following the disclosure of the sales decline, James Hardie's share price dropped over 34%, from $28.43 per share on August 18, 2025, to $18.64 per share on August 20, 2025 [4] Legal Context - The class action lawsuit is based on allegations of violations of federal securities laws due to the failure to disclose significant information that impacted investor decisions during the specified Class Period [3]

Core Points - A class action lawsuit has been filed against James Hardie Industries plc for allegedly making false and misleading statements regarding its North America Fiber Cement segment, which experienced weakening demand [3][7] - The lawsuit claims that James Hardie misrepresented the strength of demand and inventory levels, leading to a significant drop in share price after a 12% sales decline was disclosed [3][7] Allegation Details - The complaint alleges that James Hardie's North America Fiber Cement segment was facing weakening demand due to distributor inventory destocking known to the company by April and early May 2025 [3] - Despite this knowledge, the company falsely represented that demand remained strong and inventory levels were "normal" [3] - On August 19, 2025, James Hardie revealed a 12% sales decline in the segment, attributing it to "normalization of channel inventories," and warned of continued weakness [3] - Following this announcement, the company's share price dropped more than 34%, damaging investors [3] Next Steps - Investors who purchased or acquired James Hardie shares during the class period (May 20, 2025, to August 18, 2025) and suffered losses are encouraged to contact the law firm for more information [4][7] - There is no cost or obligation for investors to inquire about their rights or interests regarding the lawsuit [4]